Stay updated on TreT Safety in PAH Subjects Using Tyvaso Clinical Trial
Sign up to get notified when there's something new on the TreT Safety in PAH Subjects Using Tyvaso Clinical Trial page.

Latest updates to the TreT Safety in PAH Subjects Using Tyvaso Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new page revision v3.4.2 was added and the previous revision v3.4.1 was removed from the history. This reflects a software/UI update to the page.SummaryDifference0.1%

- Check15 days agoChange DetectedA new revision entry v3.4.1 appears in the history, replacing v3.4.0. This is a metadata update to the page history and does not affect the trial data displayed.SummaryDifference0.1%

- Check22 days agoChange DetectedUI changes include a glossary toggle, color-coded highlights for edits (green for additions, red for deletions), and removal of the No FEAR Act data note, with revision notes updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check37 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page history, indicating a minor version update that does not affect study data, records, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now lists a new entry Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 items have been removed from the footer.SummaryDifference0.2%

- Check86 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing v3.2.0. This appears to be a minor site maintenance update and does not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TreT Safety in PAH Subjects Using Tyvaso Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TreT Safety in PAH Subjects Using Tyvaso Clinical Trial page.